| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
491,390,000 |
| Market
Cap: |
8.30(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.08 - $16.46 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 11.5 |
| Insider 6 Months : 11.5 |
| Insider 3/6 Months : 23 |
|
| Guru Rank Number : 235 |
| Guru Rank Value : 5.2 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Elanco Animal Health is an animal health company. Co. groups its products into four principal categories: Companion Animal (CA) Disease Prevention, which includes parasiticides and vaccine products for canines and felines; CA Therapeutics, which includes products for the treatment of pain, osteoarthritis, otitis, cardiovascular and dermatology indications in canines and felines; Food Animal (FA) Future Protein and Health, which includes vaccines, antibiotics, parasiticides and other products used in poultry and aquaculture production; and FA Ruminants and Swine, which includes vaccines, antibiotics, implants, parasiticides and other products used in ruminants and swine production.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
38,100 |
38,100 |
38,100 |
157,300 |
| Total Buy Value |
$617,802 |
$617,802 |
$617,802 |
$2,415,734 |
| Total People Bought |
3 |
3 |
3 |
7 |
| Total Buy Transactions |
3 |
3 |
3 |
12 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Urbanek David Alan |
See Remarks |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,876 |
74,339 |
|
- |
|
| Simmons Jeffrey N |
President, CEO & Director |
• • – |
2021-03-01 |
4 |
D |
$33.65 |
$164,313 |
D/D |
(4,883) |
486,232 |
|
- |
|
| Young Todd S. |
See Remarks |
• – – |
2021-02-22 |
4 |
D |
$30.58 |
$236,139 |
D/D |
(7,722) |
58,503 |
|
- |
|
| Young Todd S. |
See Remarks |
• – – |
2021-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
25,996 |
66,225 |
|
- |
|
| Urbanek David Alan |
See Remarks |
• – – |
2021-02-22 |
4 |
D |
$30.58 |
$104,155 |
D/D |
(3,406) |
66,463 |
|
- |
|
| Urbanek David Alan |
See Remarks |
• – – |
2021-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
11,916 |
69,869 |
|
- |
|
| Meer James M |
Chief Accounting Officer |
• – – |
2021-02-22 |
4 |
D |
$30.58 |
$20,519 |
D/D |
(671) |
8,586 |
|
- |
|
| Meer James M |
Chief Accounting Officer |
• – – |
2021-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,950 |
9,257 |
|
- |
|
| Hicks Michael-Bryant |
See Remarks |
• – – |
2021-02-22 |
4 |
D |
$30.58 |
$199,779 |
D/D |
(6,533) |
57,267 |
|
- |
|
| Hicks Michael-Bryant |
See Remarks |
• – – |
2021-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
21,663 |
63,800 |
|
- |
|
| Kinard David S |
See Remarks |
• – – |
2021-02-22 |
4 |
D |
$30.58 |
$118,345 |
D/D |
(3,870) |
71,782 |
|
- |
|
| Kinard David S |
See Remarks |
• – – |
2021-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
13,540 |
75,652 |
|
- |
|
| Schacht Aaron L |
See Remarks |
• – – |
2021-02-22 |
4 |
D |
$30.58 |
$123,085 |
D/D |
(4,025) |
68,668 |
|
- |
|
| Schacht Aaron L |
See Remarks |
• – – |
2021-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
14,082 |
72,693 |
|
- |
|
| Simmons Jeffrey N |
President, CEO & Director |
• • – |
2021-02-22 |
4 |
D |
$30.58 |
$1,198,124 |
D/D |
(39,180) |
491,115 |
|
- |
|
| Simmons Jeffrey N |
President, CEO & Director |
• • – |
2021-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
89,902 |
530,295 |
|
- |
|
| Cabral Ramiro Martin |
See Remarks |
• – – |
2021-02-22 |
4 |
D |
$30.58 |
$81,802 |
D/D |
(2,675) |
48,023 |
|
- |
|
| Cabral Ramiro Martin |
See Remarks |
• – – |
2021-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
9,359 |
50,698 |
|
- |
|
| Simmons Jeffrey N |
President, CEO & Director |
• • – |
2021-02-01 |
4 |
D |
$29.81 |
$446,107 |
D/D |
(14,965) |
440,393 |
|
- |
|
| Cabral Ramiro Martin |
See Remarks |
• – – |
2020-12-31 |
4 |
D |
$30.67 |
$105,259 |
D/D |
(3,432) |
41,339 |
|
- |
|
| Kinard David S |
See Remarks |
• – – |
2020-12-31 |
4 |
D |
$30.67 |
$164,207 |
D/D |
(5,354) |
62,112 |
|
- |
|
| Urbanek David Alan |
See Remarks |
• – – |
2020-12-31 |
4 |
D |
$30.67 |
$203,526 |
D/D |
(6,636) |
57,953 |
|
- |
|
| Schacht Aaron L |
See Remarks |
• – – |
2020-12-31 |
4 |
D |
$30.67 |
$119,030 |
D/D |
(3,881) |
58,611 |
|
- |
|
| Simmons Jeffrey N |
President, CEO & Director |
• • – |
2020-12-31 |
4 |
D |
$30.67 |
$1,035,389 |
D/D |
(33,759) |
455,358 |
|
- |
|
| Sachem Head Gp Llc |
Director |
– • – |
2020-12-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
27,835,500 |
|
8% |
|
390 Records found
|
|
Page 10 of 16 |
|
|
3.37 (24.93%) 
